Leah Lawrence

This study showed that a novel CVS device provided effective, well-tolerated adjuvant prophylactic therapy for a group of adults with episodic migraine.

Here’s a quick overview of what’s new-and what may be coming-in preventive treatments strategies for migraine.

Does cerebrovascular atherosclerosis explain the connection between migraine and vascular diseases?

The top three reasons for not reporting a concussion was similar between males and females.

For several decades, studies have suggested a role for CGRP in migraine, and that targeting the CGRP pathway might help to prevent migraine.

Researchers examined two possible risk factors for migraine that potentially can be modified – having obesity and being underweight.

Is there a common biological pathway underlying ischemic stroke and migraine in young patients?

Studies have shown that true acupuncture is more effective than sham acupuncture in reducing migraine, but it treatment feasible?

A review examined risk of medication overuse headache across classes of acute migraine treatments.

SPG is known to be an effective treatment among adults with migraine, but little is known about its use in the pediatric population.

Researchers tested the efficacy of neuromodulation of the sphenopalatine ganglion to treat patients with drug-refractory cluster headaches.

Cognitive behavioral therapy to treat migraine in children and adolescents proved beneficial, but were the results long-lasting?

A trial of chiropractic spinal manipulative therapy (CSMT) to treat migraine successfully blinded its patients to the trial intervention.

Perioperative stroke is associated with a significantly increased risk for mortality and long-term morbidities. What role does migraine history play?

Research has linked rosacea with other neurologic conditions such as Parkinson disease and MS, but an association with migraine has been unclear.

There is no FDA-approved drug for pediatric migraine in children aged younger than 12, so treatment is consensus-based rather than evidence-based.

Achieving pain freedom at 2 hours and sustained pain response at 24 hours are important outcomes of any acute migraine therapy.

Nerve blocks are often used in adults and children to treat headaches, but few data look at practice patterns in a pediatric setting.

Researchers evaluated whether blood levels of PACAP could serve as a biomarker for parasympathetic activation in migraine headaches.

Triptans are contraindicated with certain CV risk factors, however, there are few data looking at the rate of triptans use among this population.

A small study of 108 patients evaluated if caffeine cessation for 2 weeks or longer could affect outcomes of acute migraine treatment.

A study of U.S. Armed Forces asks if severity of traumatic brain injury impacts the likelihood of developing headache or migraine.

Data from the Nurses’ Health Study II evaluated the risk of cardiovascular disease, myocardial infarction, and stroke in women with migraine.

Was longer treatment duration with noninvasive vagus nerve stimulation associated with a clinically significant reduction in headache days?

Explore recent migraine treatment research on the following slides.